leukotriene-e4 has been researched along with 15-hydroxy-5-8-11-13-eicosatetraenoic-acid* in 4 studies
4 other study(ies) available for leukotriene-e4 and 15-hydroxy-5-8-11-13-eicosatetraenoic-acid
Article | Year |
---|---|
Lipoxygenase products in the urine correlate with renal function and body temperature but not with acute transplant rejection.
Acute transplant rejection is the leading cause of graft loss in the first months after kidney transplantation. Lipoxygenase products mediate pro- and anti-inflammatory actions and thus we aimed to correlate the histological reports of renal transplant biopsies with urinary lipoxygenase products concentrations to evaluate their role as a diagnostic marker. This study included a total of 34 kidney transplant recipients: 17 with an acute transplant rejection and 17 controls. LTE4, LTB4, 12-HETE and 15-HETE concentrations were measured by enzyme immunoassay. Urinary lipoxygenase product concentrations were not significantly changed during an acute allograft rejection. Nevertheless, LTB4 concentrations correlated significantly with the body temperature (P ≤ 0.05) 3 months after transplantation, and 12- and 15-HETE concentrations correlated significantly with renal function (P ≤ 0.05) 2 weeks after transplantation. In conclusion, our data show a correlation for LTB4 with the body temperature 3 months after transplantation and urinary 12- and 15-HETE concentrations correlate positively with elevated serum creatinine concentrations but do not predict acute allograft rejection. Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Acute Disease; Adult; Body Temperature; Female; Graft Rejection; Humans; Hydroxyeicosatetraenoic Acids; Kidney; Kidney Transplantation; Leukotriene B4; Leukotriene E4; Lipoxygenase; Male; Middle Aged | 2013 |
Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge.
Lipoxygenase, cyclo-oxygenase and cytochrome P450 (CYP) products of arachidonic acid (AA) are implicated in pulmonary vasoregulation. The CYP-mediated epoxyeicosatrienoates (EETs) have been described previously as the predominant eicosanoids in human lungs upon stimulation with the Ca(2+) ionophore A23187. In this study, we challenged perfused human lungs with two microbial agents: Escherichia coli haemolysin (ECH) and formyl-methionyl-leucyl-phenylalanine (fMLP). Both stimuli elicited pronounced generation of leukotrienes (LTs), hydroxyeicosatetraenoic acids (HETEs), prostanoids (PTs) and EETs/dihydroxyeicosatrienoic acids (DHETs), as assessed by liquid chromatography-mass spectrometry, paralleled by pulmonary artery pressor response and lung oedema formation. The maximum buffer concentrations of EETs/DHETs surpassed those of LTs plus HETEs and PTs by a factor of four (ECH) or three (AA/fMLP). Dual 5-lipoxygenase/cyclo-oxygenase inhibition caused pronounced reduction of AA/fMLP-induced LT/PT synthesis and oedema formation but only limited attenuation of pulmonary vasoconstriction, while inhibition of CYP epoxygenase clearly attenuated AA/fMLP-induced EET/DHET synthesis and vasoconstriction but not oedema formation, suggesting a major contribution of LTs/PTs to vascular leakage and of EETs/DHETs to pressor response. Consequently, generation of EETs/DHETs is greater than that of LTs plus HETEs and PTs in ex vivo perfused human lungs upon microbial challenge suggesting a substantial contribution of these mediators to inflammatory-infectious pulmonary injury. Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Capillary Permeability; Cytochrome P-450 Enzyme System; Eicosanoids; Epoxide Hydrolases; Escherichia coli Proteins; Hemolysin Proteins; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Leukotriene E4; Lipoxygenase; Lung; N-Formylmethionine Leucyl-Phenylalanine; Perfusion; Prostaglandins; Pulmonary Circulation; Rabbits; Vasoconstriction | 2010 |
Eoxins: a new inflammatory pathway in childhood asthma.
Increased levels of leukotrienes (LTs) in exhaled breath condensate (EBC) are associated with asthma and bronchial hyperresponsiveness (BHR), whereas eicosanoids generated through the 15-lipoxygenase (LO) pathway (15-hydroxyeicosatetraenoic acid [HETE] and eoxins) have been less studied.. We investigated whether metabolites of the 5- and 15-LO pathways in EBC are associated with childhood asthma, asthma severity, and clinical parameters.. The present study included 131 school-aged children (27 children with problematic severe asthma, 80 children with mild-to-moderate asthma, and 24 healthy children) from the Severe Asthma Recognized in Childhood study and 19 children with other nonasthmatic chronic lung diseases. Clinical work-up included spirometry, fractional exhaled nitric oxide measurements, skin prick testing, and methacholine challenge. Eicosanoids were analyzed in EBC by using mass spectrometry and are reported as concentrations (in picograms per milliliter) and eicosanoid/palmitic acid (PA) ratios.. Eoxin C₄/PA, eoxin D₄/PA, eoxin E₄/PA, 15-HETE/PA, and LTC₄/PA ratios were significantly increased in asthmatic versus healthy children. Eoxin D₄/PA and LTE₄/PA ratios were also significantly higher in children with BHR. A nonsignificant trend was observed toward higher eoxin/PA ratios with increasing asthma severity. In contrast to asthma, children with chronic lung disease had the highest 15-HETE/PA, LTC₄/PA, LTE₄/PA, and LTB₄/PA ratios.. The results point to increased activity of the 15-LO inflammatory pathway in childhood asthma. Mass spectrometric analyses of EBC demonstrate that increased eoxin levels not only accompany the increased 5-LO product LTC₄ but are also associated with BHR. These markers might represent a new therapeutic target for asthma treatment. Topics: Adolescent; Arachidonate 15-Lipoxygenase; Asthma; Breath Tests; Bronchial Hyperreactivity; Child; Exhalation; Female; Humans; Hydroxyeicosatetraenoic Acids; Inflammation; Leukotriene C4; Leukotriene E4; Leukotrienes; Male; Mass Spectrometry; Severity of Illness Index | 2010 |
Effect of intravenously administered lipoxygenase metabolites on rat tracheal mucous gel layer thickness.
The effect of intravenous injections of 5-, 12- and 15-hydroxyeicosatetraenoic acids (HETE), leukotrienes D4 and E4 (LTD4, LTE4) on tracheal mucous gel layer (TMGL) thickness was assessed in rats. When administered in doses ranging from 0.03 pg to 33 ng per rat, the lipoxygenase metabolites produced significant increases in TMGL thickness. The order of potency of the metabolites was 15-HETE greater than 12-HETE greater than or equal to 5-HETE greater than LTD4 greater than or equal to LTE4. Imidazole (31.6 mg/kg), intravenously, significantly decreased this response. These findings suggest that the mono-HETEs, especially 15-HETE, may be important modulators of airway mucus in the rat. Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Hydroxyeicosatetraenoic Acids; Imidazoles; In Vitro Techniques; Injections, Intravenous; Leukotriene E4; Leukotrienes; Mucous Membrane; Mucus; Rats; SRS-A; Trachea | 1989 |